无初始辅助治疗子宫内膜癌复发后挽救性放疗的结局:一项机构回顾
挽救放疗后2年局部控制率93%、无病生存率80%、总生存率88%,治疗耐受性好,胃肠及泌尿生殖毒性低。
要点
- 未辅助治疗后局部/区域复发子宫内膜癌行挽救放疗,2年局部控制率达93%。
- 挽救放疗后2年无病生存率80%、总生存率88%,急性及慢性毒性低。
- 首次复发中位时间1.7年,局部复发中位1.2年,区域复发中位4.0年。
核心结论
- 对未接受初始辅助治疗的子宫内膜癌局部或区域复发患者,挽救性放疗可获得极好的控制且急慢性毒性低。
主要发现
- 首次复发中位时间1.7年,其中局部复发23例、区域复发4例、两者兼有1例。
- 子宫切除至首次局部复发中位1.2年,至区域复发中位4.0年。
- 挽救放疗中位总等效2 Gy分次剂量为67.6 Gy(范围37.5-81.8 Gy)。
- 挽救治疗后出现2例第二次复发,均为局部复发,分别发生于放疗后6.5和13.5个月。
- 2年局部控制率、无病生存率和总生存率分别为93%、80%和88%。
临床怎么用
- 对初始手术后未辅助治疗而出现孤立局部或区域复发的子宫内膜癌,可考虑挽救性放疗。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: After definitive surgery, women with early-stage, low-risk endometrial cancer are observed. However, some will require salvage radiation therapy for recurrence. The purpose of this study was to evaluate our experience using salvage radiation for recurrent endometrial cancer in patients who did not receive upfront adjuvant therapy. METHODS AND MATERIALS: Twenty-eight women with endometrial cancer who had undergone initial definitive hysterectomy without adjuvant therapy developed isolated local or regional recurrence and were treated with salvage radiation in our department from 2004 to 2018. Salvage radiation included whole pelvic radiation, vaginal brachytherapy, or both. Patient and tumor characteristics, treatment details, and toxicities were recorded and analyzed. RESULTS: The median time to first recurrence was 1.7 years. First recurrences consisted of local recurrence in 23 patients, regional recurrence in 4, and both in 1. The median times from hysterectomy to first recurrence, local and regional, were 1.2 and 4.0 years, respectively. All patients underwent salvage radiation for management of their first recurrence. The median total equivalent dose in 2 Gy fractions for this treatment was 67.6 Gy (37.5-81.8 Gy). Two second recurrences occurred following salvage treatment, both local recurrence, at 6.5 and 13.5 months after radiation. The 2-year rates of local control, disease-free survival, and overall survival were 93%, 80%, and 88%, respectively. Treatment was well-tolerated, with low rates of gastrointestinal and genitourinary toxicity. CONCLUSIONS: In this group of patients, salvage radiation therapy for local or regional recurrence of endometrial cancer resulted in excellent control with low rates of acute and chronic toxicities.
引用
- Arden JD, Gruner MF, Vu CC, et al. Outcomes After Salvage Radiation Therapy for Recurrent Endometrial Cancer in Patients With No Prior Adjuvant Therapy: An Institutional Review. Adv Radiat Oncol. 2020. PMID: 33305085. doi:10.1016/j.adro.2020.08.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。